Holen Sie sich die Stockscreener-App
22.02
2.31%
-0.52
Handel nachbörslich:
21.95
-0.07
-0.32%
Schlusskurs vom Vortag:
$22.54
Offen:
$22.58
24-Stunden-Volumen:
1.49M
Relative Volume:
0.81
Marktkapitalisierung:
$1.41B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-107.85M
KGV:
-9.9638
EPS:
-2.21
Netto-Cashflow:
$-106.82M
1W Leistung:
-0.36%
1M Leistung:
+0.96%
6M Leistung:
-25.13%
1J Leistung:
-41.51%
1-Tages-Spanne:
$21.68
$22.65
1-Wochen-Bereich:
$21.15
$23.81
52-Wochen-Spanne:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Vergleichen Sie VERA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
22.02 | 1.36B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-28 | Eingeleitet | Goldman | Buy |
| 2024-11-21 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Eingeleitet | Raymond James | Outperform |
| 2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-16 | Eingeleitet | Guggenheim | Buy |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Real time social sentiment graph for Vera Therapeutics Inc.2025 Key Lessons & Breakout Confirmation Alerts - Newser
What data driven models say about Vera Therapeutics Inc.’s futureQuarterly Growth Report & High Yield Stock Recommendations - Newser
Published on: 2025-08-27 08:01:05 - Newser
Vera Therapeutics Inc. stock prediction for this weekPortfolio Value Report & Safe Entry Momentum Tips - Newser
Long term hold vs stop loss in Vera Therapeutics Inc.July 2025 Outlook & Short-Term High Return Ideas - Newser
Measuring Vera Therapeutics Inc.’s beta against major indicesBear Alert & Momentum Based Trading Signals - Newser
Signal strength of Vera Therapeutics Inc. stock in tech scannersWeekly Profit Report & Fast Gain Stock Tips - Newser
Chart based analysis of Vera Therapeutics Inc. trendsEarnings Growth Summary & Safe Entry Trade Signal Reports - Newser
Quant Models Detect Momentum Reversal in Vera Therapeutics Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Strategies to average down on Vera Therapeutics Inc.2025 Support & Resistance & Fast Entry Momentum Alerts - Newser
Vera Therapeutics to Participate at Upcoming Investor Conferences - GlobeNewswire
Clinical-Stage Biotech Vera Therapeutics Announces Key September Investor Conference Schedule - Stock Titan
Custom watchlist performance reports with Vera Therapeutics Inc.Weekly Investment Recap & High Accuracy Trade Signal Alerts - Newser
Reversal indicators forming on Vera Therapeutics Inc. stockQuarterly Trade Summary & Daily Price Action Insights - Newser
Tools to assess Vera Therapeutics Inc.’s risk profileMarket Trend Report & Community Verified Watchlist Alerts - Newser
When is the best time to exit Vera Therapeutics Inc.July 2025 Selloffs & Reliable Trade Execution Plans - Newser
Vera Therapeutics shares rise 1.31% intraday after B. Riley raised price target to $16. - AInvest
What institutional flow reveals about Vera Therapeutics Inc.Market Activity Recap & AI Optimized Trade Strategies - Newser
Evercore ISI Maintains Buy Rating for Vera Therapeutics with $75 Price Target - AInvest
How to use a screener to detect Vera Therapeutics Inc. breakoutsJuly 2025 Fed Impact & Fast Gain Swing Trade Alerts - Newser
Real time social sentiment graph for Vera Therapeutics IncJuly 2025 Short Interest & Risk Controlled Daily Plans - Newser
Vera Therapeutics Inc. Stock Poised for Technical ComebackJuly 2025 Recap & Weekly High Return Stock Opportunities - beatles.ru
How to recover losses in Vera Therapeutics Inc. stockPortfolio Risk Summary & Daily Stock Trend Watchlist - Newser
Is Vera Therapeutics Inc. stock a hidden gem2025 Market Sentiment & Verified Chart Pattern Trade Signals - 더경남뉴스
Pattern recognition hints at Vera Therapeutics Inc. upsideJuly 2025 Recap & Community Verified Trade Signals - Newser
Price Consolidation Hints at Upcoming Move in Vera Therapeutics Inc.July 2025 Pullbacks & Weekly High Potential Alerts - beatles.ru
Can momentum traders help lift Vera Therapeutics Inc.July 2025 Sector Moves & Fast Exit Strategy with Risk Control - Newser
Intraday pattern recognizer results for Vera Therapeutics Inc.July 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Using flow based indicators on Vera Therapeutics Inc.Weekly Stock Recap & Growth Focused Entry Point Reports - Newser
Can Vera Therapeutics’ (VERA) Widening Losses Challenge Its Path to Sustainable Growth? - Yahoo Finance
How sentiment analysis helps forecast Vera Therapeutics Inc.July 2025 Action & Technical Pattern Based Buy Signals - Newser
Is This a Bottoming Phase for Vera Therapeutics Inc.July 2025 Outlook & AI Driven Stock Movement Reports - metrotimes.co.kr
Can Vera Therapeutics Inc. stock recover from recent declineMarket Sentiment Review & Daily Momentum Trading Reports - Newser
Why Vera Therapeutics Inc. stock attracts strong analyst attentionMarket Sentiment Review & Growth Focused Stock Pick Reports - Newser
Published on: 2025-08-17 09:44:14 - metal.it
Will a bounce in Vera Therapeutics Inc. offer an exitQuarterly Trade Review & Daily Risk Controlled Trade Plans - Newser
Will Vera Therapeutics Inc. Stock Benefit from AI and Green Energy Trends2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
What’s next for Vera Therapeutics Inc. stock price2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Should I average down on Vera Therapeutics Inc. stockMarket Sentiment Report & Stock Market Timing Techniques - newsyoung.net
Vera Therapeutics Inc. Stock Performance After Earnings: Historical InsightsGold Moves & Free Safe Entry Trade Signal Reports - Newser
Vera Therapeutics shares fall 2.84% premarket after announcing inducement grants to new employees. - AInvest
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vera Therapeutics Inc-Aktie (VERA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):